These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2842890)

  • 1. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
    Ramos K; Grossman SL; Cox LR
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
    Pino R; Lyles GA
    Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.
    Nelson TJ; Boor PJ
    Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart.
    Toraason M; Luken ME; Breitenstein M; Krueger JA; Biagini RE
    Toxicology; 1989 May; 56(1):107-17. PubMed ID: 2728003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells.
    Hysmith RM; Boor PJ
    Toxicology; 1988 Oct; 51(2-3):133-45. PubMed ID: 3140421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytotoxic responses of cultured avian and rodent aortic smooth muscle cells to allylamine.
    Ramos KS; Thurlow CH
    J Toxicol Environ Health; 1993 Sep; 40(1):61-76. PubMed ID: 8360943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
    Conklin DJ; Trent MB; Boor PJ
    Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
    Conklin DJ; Langford SD; Boor PJ
    Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semicarbazide-sensitive amine oxidase activity in rat aortic cultured smooth muscle cells.
    Blicharski JR; Lyles GA
    J Neural Transm Suppl; 1990; 32():337-9. PubMed ID: 2128506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amine metabolism: a novel path to coronary artery vasospasm.
    Conklin DJ; Boyce CL; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 2001 Sep; 175(2):149-59. PubMed ID: 11543647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
    Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.
    Eriksson M; Fowler CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):273-8. PubMed ID: 6514011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
    Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
    Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart.
    Guffroy C; Fowler CJ; Strolin Benedetti M
    J Pharm Pharmacol; 1983 Jul; 35(7):416-20. PubMed ID: 6136581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An allylamine derivative (MDL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase.
    Lyles GA; Fitzpatrick CM
    J Pharm Pharmacol; 1985 May; 37(5):329-35. PubMed ID: 2862241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery.
    Precious E; Lyles GA
    J Pharm Pharmacol; 1988 Sep; 40(9):627-33. PubMed ID: 2907029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro.
    He N; Singhal SS; Awasthi S; Zhao T; Boor PJ
    Toxicol Appl Pharmacol; 1999 Jul; 158(2):177-85. PubMed ID: 10406932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
    Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine.
    Awasthi S; Boor PJ
    Toxicol Lett; 1993 Feb; 66(2):157-63. PubMed ID: 8430435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta.
    Precious E; Gunn CE; Lyles GA
    Biochem Pharmacol; 1988 Feb; 37(4):707-13. PubMed ID: 3342102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.